The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
Título
The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.
Autor
Giovanna Liuzzo, Carlo Patrono
Fecha
2020
Identificador
10.1093/eurheartj/ehaa935
Fuente
European heart journal
Archivos
Colección
Citación
Giovanna Liuzzo, Carlo Patrono, “The widely promoted antimalarial drug hydroxychloroquine confers no mortality benefit in hospitalized patients with COVID-19: comment on the 'Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19'.,” SOCICT Open, consulta 20 de abril de 2026, https://socictopen.socict.org/items/show/8151.
Position: 19766 (14 views)